异基因移植后益生元纤维肠内补充的可行性与对微生物组的影响
这项先导研究比较了异基因造血干细胞移植后接受标准肠内营养(n=10)与含益生元纤维肠内营养(n=20)患者的耐受性、临床、微生物组及代谢组结局。益生元组移植后每日纤维摄入平均22 g/d,标准组为4 g/d;两组肠内营养耐受性均高,需肠外营养者标准组20%(n=2)、益生元组15%(n=3)(P=1.0)。两组微生物多样性均下降且补充后无差异(P=.93),但益生元组仅鼠李糖乳杆菌C相对丰度增加(P=.022),标准组Faecalicatena gnavus相对丰度升高而益生元组下降(P=.0027)。
要点
- 益生元纤维肠内营养使移植后每日纤维摄入平均达22 g/d,标准肠内营养组为4 g/d。
- 两组肠内营养耐受性均高,需肠外营养者标准组20%(n=2) vs 益生元组15%(n=3),P=1.0。
- 益生元组仅鼠李糖乳杆菌C相对丰度增加(P=.022),抗生素耐药基因表达仅在益生元组补充后下降(P=.00035)。
核心结论
- 异基因造血干细胞移植后提供含益生元纤维的肠内营养配方可行且耐受性高,微生物多样性在两组均下降且补充后无差异。
- 作者认为应试验更长时间的纤维干预以优化临床结局和更多样的微生物组。
研究设计与样本
- 先导研究,比较异基因造血干细胞移植后接受标准肠内营养(n=10)与含益生元纤维肠内营养(n=20)患者的耐受性、临床、微生物组及代谢组结局。
- 在基线和植入前后采集粪便样本,采用鸟枪法宏基因组测序分析。
- 试验在www.anzctr.org.au注册,注册号为#ACTRN12621000832875。
主要发现
- 益生元肠内营养组移植后每日纤维摄入平均22 g/d,标准肠内营养组为4 g/d。
- 需肠外营养者标准组20%(n=2) vs 益生元组15%(n=3),P=1.0;两组肠内营养提供量、持续时间或临床结局无差异。
- 两组微生物多样性均下降,补充后无差异(P=.93)。
- 鼠李糖乳杆菌C相对丰度仅益生元组增加(P=.022);Faecalicatena gnavus相对丰度标准组升高而益生元组下降(P=.0027)。
- 微生物基因组功能分析显示抗生素耐药基因表达仅在益生元组肠内营养补充后下降(P=.00035)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 作者认为应试验更长时间的纤维干预以优化临床结局和更多样的微生物组。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The decline in diversity of the gastrointestinal microbiome during hematopoietic stem cell transplantation (HSCT) is associated with poorer clinical outcomes. Although provision of enteral nutrition (EN) is common during HSCT, provision of a prebiotic fiber-containing formula has not been explored. This pilot study compared tolerance, clinical, microbiome, and metabolomic outcomes between patients who received standard EN (n = 10) vs prebiotic fiber EN (n = 20) after allogeneic HSCT. Stool samples were collected at baseline and at periengraftment and were analyzed with shotgun metagenomic sequencing. Provision of prebiotic EN increased daily fiber intake after transplant to an average 22 g/d compared with 4 g/d in the standard-care group. High tolerance of both EN formulas was observed with only 20% (n = 2) of the standard and 15% of the prebiotic group (n = 3) requiring parenteral nutrition (P = 1.0). There was no difference in the amount of EN provided, EN duration, or clinical outcomes. Microbial diversity declined in both groups with no difference post-EN provision (P = .93), however, there was a significant difference in relative abundance of Lactobacillus_C rhamnosus, with an increase in the prebiotic group only (P = .022). The relative abundance of Faecalicatena gnavus increased in the standard group and declined in the prebiotic group (P = .0027). Functional analysis of the microbial genome showed decreased expression of antibiotic resistance genes in the prebiotic group only after EN provision (P = .00035). A longer fiber intervention should be trialed to optimize clinical outcomes and a more diverse microbiome. The trial was registered at www.anzctr.org.au as #ACTRN12621000832875.
引用
- Andersen S, Kennedy G, Banks M, et al. Prebiotic fiber enteral supplementation after allogeneic transplantation: feasibility and impact on the microbiome. Blood Adv. 2025. PMID: 40489796. doi:10.1182/bloodadvances.2024015703
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。